Legal
Two weeks after filing a lawsuit against his former company from prison, Martin Shkreli has reached a settlement with Retrophin.
Lawsuits against the FDA are fairly common. However, winning the lawsuit will be a tough road for Catalyst, as other pharma companies that challenged the regulatory agency learned.
Complaint Cites Multiple Violations of Food, Drug, and Cosmetic Act
Novartis was alleged to have held about 80,000 sham events where doctors were wined and dined in order to boost sales of key medications.
The decision, which is likely to be appealed, will allow Dana-Farber to license the technology.
The plaintiffs allege that Gilead and other companies used anticompetitive tactics to keep prices artificially high for their respective HIV treatments.
Purdue, Bristol-Myers Squibb and Apotex have been singled out in opioid-related lawsuits in Canada.
Bayer said the award conflicts with an April report from the EPA that says glyphosate, the active ingredient in Roundup, is not a carcinogen.
Insys owes more than $240 million in legal-related fees but the company only has about $87 million in available cash.
The two generic drugmakers, along with many others, have been accused of conspiring to inflate the price of more than 100 generic drugs.
PRESS RELEASES